CovPall: Improving palliative care for people affected by the COVID-19 pandemic by sharing learning – the national and international response

Rapid evaluation of the COVID-19 pandemic response in PALLiative and end of life care: national delivery, workforce and symptom management (CovPall) CovPall-Connect: Evaluation of the COVID-19 pandemic response in palliative and end of life care: connecting to boost impact and data assets

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN16561225

Enrollment

200

Registered

2020-07-27

Start date

2020-04-24

Completion date

Unknown

Last updated

2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 (SARS-CoV-2 infection), palliative and end of life care Infections and Infestations

Interventions

WP1: Online survey of palliative care providers, with in-depth qualitative case study of sampled providers. Data will be collected using REDCap. WP2: Cohort study of people with COVID-19 receiving p

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: WP1: Clinical leads of palliative and hospice care services including: palliative care teams in acute hospitals, in-patient hospices/palliative care wards and palliative care community services providing care in peoples own homes and supporting care homes, usually for adults and children. WP2: Consecutive patients supported by the participating palliative care services in WP1 (including remote consultation), with clinically diagnosed and/or test confirmed COVID-19 diagnosis. This will include patients with and without pre-existing progressive conditions.

Exclusion criteria

Exclusion criteria: WP1: No lead or delegate available WP2: Patients who are <18 years old

Design outcomes

Primary

Measure	Time frame
WP1. Innovations in services, workforce and volunteer deployment, and their impacts on care and bereavement services; identification of good practice, and sharing of approaches and knowledge. Change in practice, most effective treatments collected at baseline and 6-8 weeks later WP2. Symptom and problem assessment measured using IPOS score at first assessment (baseline, T0), 24-hour follow-up, ideally twice, but this will depend on survival (T1, T2), and then at death or discharge (D or Di)	—

Measure

Time frame

WP1. Innovations in services, workforce and volunteer deployment, and their impacts on care and bereavement services; identification of good practice, and sharing of approaches and knowledge. Change in practice, most effective treatments collected at baseline and 6-8 weeks later WP2. Symptom and problem assessment measured using IPOS score at first assessment (baseline, T0), 24-hour follow-up, ideally twice, but this will depend on survival (T1, T2), and then at death or discharge (D or Di)

—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

Argentina, Australia, Brazil, Canada, England, India, Ireland, Netherlands, Portugal, South Africa, Switzerland, United Kingdom

Contacts

Public ContactRachel Cripps

palliativecare@kcl.ac.uk-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 25, 2026